Publicaciones científicas en Inglés. 2017

Coll-Vinent B, Martín A, Sánchez J, Tamargo J, Suero C, Malagón F, Varona M, Cancio M, Sánchez S, Carbajosa J, Ríos J, Casanovas G, Ràfols C, Del Arco C; EMERG-AF Investigators.
Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).
Stroke. 2017 Apr 7. pii: STROKEAHA.116.014855. doi: 10.1161/STROKEAHA.116.014855. [Epub ahead of print] PMID: 28389612

Ruilope LM, Tamargo J.
Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension.
Am J Hypertens. 2017 Feb 20. doi: 10.1093/ajh/hpx010. [Epub ahead of print] PMID: 28338714

Tamargo J, Rosano G, Thomas W, Duarte J, Niessner A, Kaski JC, Cecconi C, Drexel H, Kjeldsen K, Savarese G, Torp-Pedersen C, Atar D, Lewis BS, Agewall S.
Gender differences in the effects of cardiovascular drugs.
Eur Heart J Cardiovasc Pharmacother. 2017 Feb 28. doi: 10.1093/ehjcvp/pvw042. [Epub ahead of print]. PMID: 28329228

Tamargo J, Rosano GM, Delpón E, Ruilope L, López-Sendón J.
Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.
Int J Cardiol. 2017 Apr 15;233:1-11. doi: 10.1016/j.ijcard.2016.11.124. Review.

Stefan Agewall, John Camm, Gonzalo Barón Esquivias, Werner Budts, Scipione Carerj, Filip Casselman, Antonio Coca, Raffaele De Caterina, Spiridon Deftereos, Dobromir Dobrev, José M Ferro, Gerasimos Filippatos, Donna Fitzsimons, Bulent Gorenek, Maxine Guenoun, Stefan H Hohnloser, Philippe Kolh, Gregory YH Lip, Athanasios Manolis, John McMurray, Piotr Ponikowski, Raphael Rosenhek, Frank Ruschitzka, Irina Savelieva, Sanjay Sharma, Piotr Suwalski, Juan Luis Tamargo, Clare J Taylor, Isabelle C Van Gelder, Adriaan A Voors, Stephan Windecker, José Luis Zamorano, Katja Zeppenfeld, Grupo de Trabajo de la Sociedad Europea de Cardiología.
Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS.
Rev Esp Cardiol. 2017;70(1):e1/50-e84. doi: 10.1016/j.recesp.2016.11.014

Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H.
Comprehensive efforts to increase adherence to statin therapy.
Eur Heart J. 2017 Jan 10. pii: ehw628. doi: 10.1093/eurheartj/ehw628. [Epub ahead of print] Review.  PMID: 28077470

Caballero R, Utrilla RG, Amorós I, Matamoros M, Pérez-Hernández M, Tinaquero D, Alfayate S, Nieto-Marín P, Guerrero-Serna G, Liu QH, Ramos-Mondragón R, Ponce-Balbuena D, Herron T, Campbell KF, Filgueiras-Rama D, Peinado R, López-Sendón JL, Jalife J, Delpón E, Tamargo J.
Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E416-E425. doi: 10.1073/pnas.1612383114. PMID: 28049825

Arribas F; SEC Working Group for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:., Arribas F, Roldán I, Luis Merino J, Roldán V, Arenal Ÿ, Tamargo J, Ruiz-Granell R, Mont L, Anguita M, Marín F; Reviewers for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:., Barrios Alonso V, Barón G, Esquivias, Cosín Sales J, Díaz Infante E, Escobar Cervantes C, Ferreiro Gutiérrez JL, Guerra Ramos JM, Jiménez Candil FJ, Pérez Castellano N, Sambola Ayala A, Tello Montoliu A; SEC Guidelines Committee:., San Román A, Alfonso F, Arribas F, Evangelista A, Ferreira I, Jiménez M, Marín F, de Isla LP, Rodríguez Padial L, Sánchez PL, Sionis A, Vázquez R.
Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation.
Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):2-8. doi: 10.1016/j.rec.2016.11.032. PMID: 28038728

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol Ç, Fitzsimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GY, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S; Authors/Task Force Members.; ESC Committee for Practice Guidelines (CPG).; Document Reviewers.
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Eur J Heart Fail. 2017 Jan;19(1):9-42. doi: 10.1002/ejhf.654.